First Clinical Medical School, Shanxi Medical University, Taiyuan, 030001, China.
Department of Head and Neck Surgery, Shanxi Provincial Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, 031000, Shanxi Province, China.
J Cancer Res Clin Oncol. 2024 Oct 6;150(10):447. doi: 10.1007/s00432-024-05975-0.
Gallbladder carcinoma is the most common malignant tumor of the biliary system, and has a poor overall prognosis. Poor prognosis in patients with gallbladder carcinoma is associated with the aggressive nature of the tumor, subtle clinical symptoms, ineffective adjuvant treatment, and lack of reliable biomarkers.
Therefore, evaluating the prognostic factors of patients with gallbladder carcinoma can help improve diagnostic and treatment methods, allowing for tailored therapies that could benefit patient survival.
This article systematically reviews the factors affecting the prognosis of gallbladder carcinoma, with the aim of evaluating prognostic risk in patients.
A comprehensive and in-depth understanding of prognostic indicators affecting patient survival is helpful for assessing patient survival risk and formulating personalized treatment plans.
胆囊癌是胆道系统最常见的恶性肿瘤,整体预后较差。胆囊癌患者预后不良与肿瘤侵袭性、临床症状不明显、辅助治疗效果不佳以及缺乏可靠的生物标志物有关。
因此,评估胆囊癌患者的预后因素有助于改善诊断和治疗方法,提供针对患者的个体化治疗,从而提高患者的生存率。
本文系统回顾了影响胆囊癌预后的因素,旨在评估患者的预后风险。
全面深入地了解影响患者生存的预后指标有助于评估患者的生存风险并制定个体化治疗方案。